{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02617"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":30.05,"timestamp":1752112766758,"preClose":30.85,"halted":0,"volume":23500,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.7866981900164065,"marketStatus":"Trading","change":-0.8,"latestTime":"07-10 09:59:30","open":30,"high":30.8,"low":30,"amount":713075,"amplitude":0.025932,"askPrice":30.3,"askSize":3000,"bidPrice":30,"bidSize":2500,"shortable":0,"etf":0,"ttmEps":-0.7866981900164065,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1752120000000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":30.85,"openAndCloseTimeList":[[1752111000000,1752120000000],[1752123600000,1752134400000]],"volumeRatio":0.46366,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.786698,"volumeRatio":0.46366,"shares":396897633,"dividePrice":0,"high":30.8,"amplitude":0.025932,"preClose":30.85,"low":30,"week52Low":20.2,"pbRate":"20.78","week52High":35,"institutionHeld":0,"latestPrice":30.05,"committee":-0.090909,"eps":-0.7866981900164065,"divideRate":0,"volume":23500,"delay":0,"ttmEps":-0.7866981900164065,"open":30,"prevYearClose":13.15,"prevWeekClose":33.95,"prevMonthClose":30.15,"prevQuarterClose":30.15,"fiveDayClose":29.05,"twentyDayClose":13.15,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02617\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545778427","title":"TransThera Gets US FDA Fast Track Designation for Prostate Cancer Drug; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545778427","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545778427?lang=en_us&edition=fundamental","pubTime":"2025-06-24 10:01","pubTimestamp":1750730465,"startTime":"0","endTime":"0","summary":"TransThera Sciences  said the US Food and Drug Administration has granted fast-track designation for tinengotinib to treat metastatic castration-resistant prostate cancer , according to a Tuesday Hong Kong bourse filing.In a phase 1/2 study, the drug showed a 46% objective response rate and 85% disease control rate among 13 mCRPC patients with measurable disease, the filing said.TransThera said the latest designation reflects consistent clinical execution and supports further development of the drug for advanced prostate cancer.Shares of the clinical-stage biopharmaceutical firm rose about 3% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4104","02617","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","FAST","BK4585","IE00BFXG0V08.USD","BK4588","BK4567"],"gpt_icon":1},{"id":"2545271254","title":"BRIEF-Transthera Sciences (Nanjing) Inc Says Grant Of Tinengotinib (Tt-00420) Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2545271254","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545271254?lang=en_us&edition=fundamental","pubTime":"2025-06-24 09:59","pubTimestamp":1750730399,"startTime":"0","endTime":"0","summary":"BRIEF-Transthera Sciences  Inc Says Grant Of Tinengotinib  Fast Track DesignationJune 24  - TransThera Sciences  Inc 2617.HK:GRANT OF TINENGOTINIB  FAST TRACK DESIGNATION FOR TREATMENT OF MCRPC BY US FDAFurther company coverage: 2617.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SQ0VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545287744","title":"Transthera Sciences (Nanjing) Inc - Grant of Tinengotinib (Tt-00420) Fast Track Designation for Treatment of Mcrpc by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545287744?lang=en_us&edition=fundamental","pubTime":"2025-06-24 06:08","pubTimestamp":1750716518,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nFWN3SQ0VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02617"],"gpt_icon":0},{"id":"1112813016","title":"HK Movers | Biopharmaceutical Company TransThera Soars 80% on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1112813016","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112813016?lang=en_us&edition=fundamental","pubTime":"2025-06-23 11:13","pubTimestamp":1750648381,"startTime":"0","endTime":"0","summary":"On debut today, Biopharmaceutical company TransThera soared 80% in Hong Kong.The company has yet to bring any products to market, but it has six drug candidates in clinical trials and one in pre-clini","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b427ba95419e94342a8c5dcdde518cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":1}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-07-08","current":-40.285196,"percent":0.181818,"low":-44.802949,"twenty":-40.181616,"median":-36.616858,"eighty":-32.169671,"high":-17.403134,"avg":-35.62652,"sd":6.828912,"marketCap":12105377806},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-08","current":-40.285196,"twenty":-40.181616,"median":-36.616858,"eighty":-32.169671,"marketCap":12105377806}],"updateTime":1752092808439}}}